Damascus University — Biomedical Watch V2

Traitements3programmes

Essais1liés

Publications0liées

SourceDBlocale

Traitements

3

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
IVIG (Intravenous Immunoglobulin)This study compares the clinical effectiveness of Intravenous Immunoglobulin (IVIG) versus Plasma Exchange (PLEX) in patients experiencing a myasthenic crisis. Clinical response is evaluated 14 days post-treatment using the Quantitative Myasthenia Gravis Score (QMG). Additionally, the study aims to identify and report common precipitating factors for myasthenic attacks, such as respiratory infections or surgical stress.	Myasthénie	Non applicable	À vérifier	Syria	À vérifier
Plasma exchange (PE)This study compares the clinical effectiveness of Intravenous Immunoglobulin (IVIG) versus Plasma Exchange (PLEX) in patients experiencing a myasthenic crisis. Clinical response is evaluated 14 days post-treatment using the Quantitative Myasthenia Gravis Score (QMG). Additionally, the study aims to identify and report common precipitating factors for myasthenic attacks, such as respiratory infections or surgical stress.	Myasthénie	Non applicable	À vérifier	Syria	À vérifier
IVIG (Intravenous Immunoglobulin)This study compares the clinical effectiveness of Intravenous Immunoglobulin (IVIG) versus Plasma Exchange (PLEX) in patients experiencing a myasthenic crisis. Clinical response is evaluated 14 days post-treatment using the Quantitative Myasthenia Gravis Score (QMG). Additionally, the study aims to identify and report common precipitating factors for myasthenic attacks, such as respiratory infections or surgical stress.	Myasthénie	Non applicable	À vérifier	Syria	À vérifier

Essais cliniques

1

Molécule	Indication / population	Phase	NCT	Titre	Statut
IVIG (Intravenous Immunoglobulin)	Myasthénie	Non applicable	NCT07532707	Efficacy of IVIG Versus PLEX in Myasthenic Crisis in Syria.	COMPLETED

Publications

0

Molécule	Indication / population	Titre	Journal	Date
Aucune publication.